Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2000
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphomaL J Johnston, K E Stockerl-Goldstein, W W Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Numbers of host "helper" T cells and proliferating cells predict survival in diffuse small-cell lymphomasL J Medeiros, L J Picker, A B Gelb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
Response criteria for NHL: importance of 'normal' lymph node size and correlations with response ratesA J Grillo-López, B D Cheson, S J Horning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trialP J Stiff, S Dahlberg, S J Forman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary dataS J Horning, N J Chao, R S Negrin, et al.
Pageof 10